Metis Genetics Advisors
ALBERTO L. ROSA, MD PhD
Trusted Advisor, Neurogenetics and International Affairs
Alberto L. Rosa, MD PhD is a Medical Geneticist and Molecular Biologist with expertise in general Clinical Genetics, Neurogenetics and Molecular Diagnostics. He obtained his academic degrees in both Medicine and Chemistry, completing his two PhD degrees in the respective disciplines (e.g. Clinical Genetics and Molecular Biology). Dr. Rosa developed his clinical and medical research activities in both France and the US, being Associate Professor at Baylor College of Medicine (TX), Research Professor at Washington State University (WA) and Co-Director of the Molecular Diagnostic Laboratory of the Sacred Heart Medical Center (WA). Dr. Rosa’s corporate experience includes the founding of GENBIOMOL, a successful molecular diagnostic laboratory, and serving as Chief Medical Officer and Board Director. He was recognized by the Howard Hughes Medical Institute as an International Researcher (1997-2002) and has received numerous awards both for teaching and for research. Dr. Rosa has published about 50 peer-reviewed articles on topics related to clinical genetics and molecular biology and is currently Chairman of the Department of Clinical Genetics and Director of the Molecular Diagnostics Laboratory of Sanatorio Allende (Argentina). He is also an advisor of the Latin America’s Teletons, health care organizations devoted to patients with rare diseases, neuromuscular disorders and inherited diseases. His medical consulting expertise included patients from all around the world, including the US, Europe, Mexico as well as Central and South America. Dr. Rosa contributes to Metis his international expertise in genetics as well as his knowledge on the richness of the wide cultural identities among Spanish patients.
Stephanie M. Ware, MD PhD
Trusted Advisor, Cardiogenetics
Stephanie M. Ware, MD, PhD, is a Professor of Pediatrics and Medical and Molecular Genetics, Vice Chair of Clinical Affairs in Medical and Molecular Genetics, and Program Leader in Cardiovascular Genetics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine. Dr. Ware graduated Summa cum laude with highest honors in Zoology from Butler University. She earned her MD and PhD degrees at the University of Cincinnati College of Medicine where she was elected to Alpha Omega Alpha Honor Society. She completed her pediatric residency and clinical genetics fellowship at Baylor College of Medicine in Houston, Texas. Dr. Ware’s research interests include the genetic and developmental basis of disorders of cardiac structure and function. Her research laboratory has made significant contributions in the areas of congenital heart defects and cardiomyopathy. Dr. Ware is a member of the American Heart Association, the American Society for Human Genetics, the Society for Pediatric Research, the American Society for Clinical Investigation, and is Faculty of the American College of Medical Genetics and Genomics. She has received a number of scholarly awards for her research. Dr. Ware has a longstanding track record of independent funding from the NIH and multiple foundations for basic and translational research. In addition, she participates in multi-site initiatives including serving as PI of the Genetic Coordinating Center for the NHLBI funded study to identify genotype-phenotype correlations in pediatric cardiomyopathy and serving as PI for the Cytogenomics of Cardiovascular Malformations Consortium. The long term goals of the clinical, translational, and basic research approaches are to identify causes and potential management of disorders of cardiac structure and function. Clinically, she evaluates and manages patients with genetic disorders and has specific expertise in cardiomyopathy and syndromes with cardiovascular disease. She was recruited to IUSM in March, 2014 to initiate a cardiovascular genetics program that would encompass clinical cardiovascular genetics services and basic and translational cardiovascular genetics research.
Joy B. Redman, MS, LCGC, MBA
Trusted Advisor, Genetic Counseling and Molecular Genetics
Joy Redman is a licensed genetic counselor with over 30 years of experience in clinical and laboratory genetics and genetic counseling. She worked as a prenatal genetic counselor at Baylor College of Medicine and at the Laboratories for Genetics Services, where she provided counseling for high risk pregnant patients and developed satellite clinics. She worked as a clinical and research genetic counselor at the National Eye Institute of the NIH, seeing patients with inherited retinal disease and contributing to research to identify glaucoma predisposing genes. Since joining Quest Diagnostics in 2001, she has had a continued focus on molecular genetics and the translation of that information between the laboratory and clinician, to help ensure appropriate patient care. She provides consultation and guidance on appropriate test ordering to healthcare providers. She provides education to the lay public, commercial teams, and healthcare providers regarding Quest’s genetic test offerings. During her tenure at Quest, she has served as co-manager of the genetic counselor organization and helped to triple the size of the team. She currently serves as a Senior Manager on the Genomic Services team.
Joy earned her Bachelors degree in Zoology from the University of Wisconsin-Madison, her Masters degree in Human Genetics from Sarah Lawrence College, and her MBA from the University of Redlands.
L. Thomas Richards, MD
Trusted Advisor, Finance and Corporate Strategy
L. Thomas Richards, MD has more than 20 years of professional experience in the industries of healthcare and finance. Most recently, he served as the interim CEO of One BioMed, a Singapore-based molecular diagnostics company developing novel, silicon biophotonics technology for clinical infectious disease testing at the point-of-care. He also serves as a Senior Advisor to Nanomix, an immunology-based point-of-care diagnostics company focused in the areas of sepsis and cardiology for the emergency medicine market in addition to his advisory role at Metis Genetics. Prior to that, Dr. Richards led an emerging molecular diagnostics company as the CEO of TessArae, which designed genetic tests for the reproductive health and infectious disease markets.
Dr. Richards became a life sciences executive after practicing as an academic physician on the clinical faculty of Stanford University and UCSF, where he was most recently an Assistant Professor of Emergency Medicine. Before attending medical school, Dr. Richards began his career as an investment banker in the mergers and acquisitions groups of several firms in New York, including Lazard Frères, UBS and SG Cowen. He has broad transactional experience in finance, having executed buy and sell-side M&A assignments, public and private capital raisings and leveraged buyouts.
Dr. Richards also has more than a decade of experience in board leadership. He has served as a Director of both public and private companies, including: Cowen Group; TessArae and One BioMed; and Witt/Kieffer.
M.D., Harvard Medical School, Boston, MA
M.Phil., English, University of Sydney, Sydney, Australia
B.A., English, Yale University, New Haven, CT